Nanogel-Facilitated In-Situ Delivery of a Cataract Inhibitor.
Nanogel-Facilitated In-Situ Delivery of a Cataract Inhibitor.
复制标题
DOI:
10.3390/biom11081150
复制
发表时间:
2021-08-04
期刊:
影响因子:
5.5
通讯作者:
Petrash JM
中科院分区:
文献类型:
--
作者:
Gautam D;Pedler MG;Nair DP;Petrash JM
Cataracts are a leading cause of blindness worldwide. Surgical removal of cataracts is a safe and effective procedure to restore vision. However, a large number of patients later develop vision loss due to regrowth of lens cells and subsequent degradation of the visual axis leading to visual disability. This postsurgical complication, known as posterior capsular opacification (PCO), occurs in up to 30% of cataract patients and has no clinically proven pharmacological means of prevention. Despite the availability of many compounds capable of preventing early steps in PCO development, there is currently no effective means to deliver such therapies into the eye for a suitable duration. To model a solution to this unmet medical need, we fabricated acrylic substrates as intraocular lens (IOL) mimics scaled to place into the capsular bag of the mouse lens following a mock-cataract surgery. Substrates were coated with a hydrophilic crosslinked acrylate nanogel designed to elute Sorbinil, an aldose reductase inhibitor previously shown to suppress PCO. Insertion of the Sorbinil-eluting device into the lens capsule at the time of cataract surgery resulted in substantial prevention of cellular changes associated with PCO development. This model demonstrates that a cataract inhibitor can be delivered into the postsurgical lens capsule at therapeutic levels.
登录
查看更多内容
影响因子:
14
作者:
Lei, Ming;Peng, Zihang;Zhao, Chunshun
通讯作者:
Zhao, Chunshun
影响因子:
6
作者:
Saika, S;Kono-Saika, S;Roberts, AB
通讯作者:
Roberts, AB
影响因子:
13.7
作者:
JAVITT, JC;TIELSCH, JM;STEINBERG, EP
通讯作者:
STEINBERG, EP
影响因子:
--
作者:
Chang KC;Petrash JM
通讯作者:
Petrash JM
影响因子:
5.1
作者:
Hupy ML;Pedler MG;Shieh B;Wang D;Wang XJ;Petrash JM
通讯作者:
Petrash JM